NCT04949932

Brief Summary

Acne is a common problem in adolescence to young adult. But there is no such remedy available for acne treatment which has no side effects. Different types of herbs powder has been using in patients with acne vulgaris in the traditional practice of Indian subcontinent as single form or compound. Scientific evidence have shown many herbs has no known side effects and effective on acne. These herbs have antibacterial, anti-inflammatory and anti-oxidant effects. So, This study is intended to find out an inexpensive and safe alternative by using some common herbs such as Azadirachta indica, Curcuma longa, Lens culinaris Mentha arvensis and Trigonella foenum-graecum. The aim of the study is to evaluate the clinical efficacy of Poly herbal powder (PHP) for treating patients with acne vulgaris. Total of 42 adults with acne vulgaris was recruited for this study. Study subjects was included both of male and female with age limit of 18 to 35 years. Duration of study is 05 months with "day one advertisement" for screening followed by randomization for the treatment. The duration of active participation of each study subject was 3 consecutive weeks or 21days. Difference of baseline and post intervention mean by Total lesion Count (TLC) compared with placebo and assesses the % of reduction of acne based on The Global Acne Grading System (GAGS) score. Safety assessment was obtained from the incidence and type of adverse events during study period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 3, 2021

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2021

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 20, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 2, 2021

Completed
Last Updated

July 2, 2021

Status Verified

July 1, 2021

Enrollment Period

12 days

First QC Date

June 20, 2021

Last Update Submit

July 1, 2021

Conditions

Keywords

Poly-herbalAcne vulgarisPowderRCTBangladesh

Outcome Measures

Primary Outcomes (1)

  • Change in Total Lesions Count (TLC)

    Total Lesions Count (TLC) = Comedones + Papules + Pastules, before and after intervention will be presented as percentage as well as mean and standard deviation.

    03 weeks

Secondary Outcomes (2)

  • Change in The Global Acne Grading System score

    03 weeks

  • Change in non-inflammatory and inflammatory lesions count

    03 weeks

Study Arms (2)

Intervention Arm

EXPERIMENTAL

Poly herbal powder (PHP)

Other: Mixed powder of Lens culinaris, Curcuma longa, Mentha arvensis, Azadirachta indica, and Trigonella foenumgraecum.

Placebo Arm

PLACEBO COMPARATOR

Powder of Cicer arietinum

Other: Cicer arietinum powder

Interventions

Study subjects were prescribed either PHP or placebo once daily at night for 3 weeks consecutively. A dose of 1-2 tea spoonfuls powder had to mixed with water to make paste. Then it was applied on face (except around the eyes) and had to wait for 20-30 minutes until it dries.Then they were washed face by using normal water.

Intervention Arm

Study subjects were prescribed either PHP or placebo once daily at night for 3 weeks consecutively. A dose of 1-2 tea spoonfuls powder had to mixed with water to make paste. Then it was applied on face (except around the eyes) and had to wait for 20-30 minutes until it dries.Then they were washed face by using normal water.

Placebo Arm

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women both aged between 18-35 years
  • Presenting minimum 5 acne lesions (whiteheads, blackheads, papules, pustules, nodules)
  • Study subject who will be agreed with Online informed consent.

You may not qualify if:

  • Have infected acne lesions
  • If study subject suffers from any serious medical conditions such as uncontrolled hypertension, diabetes mellitus, past or current malignancy, liver or kidney dysfunction, active pulmonary tuberculosis other severe dermatitis, or any infectious or systemic diseases.
  • Use of a topical medication containing steroids for the treatment of skin disease more than once per month.
  • Hypersensitive skin.
  • Erythema, or telangiectasia at the test site.
  • Use of the same or similar cosmetics (or pharmaceutical) on the test site within three months of screening.
  • Having undergone a skin peeling or having wrinkles removed within six months.
  • Any other reasons of unsuitability for the clinical trial at the discretion of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hamdard University Bangladesh

Munshiganj, 1510, Bangladesh

Location

MeSH Terms

Conditions

Acne Vulgaris

Interventions

turmeric extractfenugreek seed meal

Condition Hierarchy (Ancestors)

Acneiform EruptionsSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland Diseases

Study Officials

  • Dr.Md. S Uddin, BUMS

    MPH student, Hamdard University Bangladesh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 20, 2021

First Posted

July 2, 2021

Study Start

April 3, 2021

Primary Completion

April 15, 2021

Study Completion

May 12, 2021

Last Updated

July 2, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share

All Individual Participant Data that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Starting 6 months after publication.
Access Criteria
Request by email.

Locations